IMP3 has been shown to be overexpressed in testicular cancer, renal cell carcinoma, ovarian carcinoma, gastric cancer, colon cancer and adenocarcinoma of the lung (6–15). The gene discussed is IMP3; the disease is hereditary clear cell renal cell carcinoma.